3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
85
Lymphoma, Follicular
53
Lymphoma
50
Lymphoma, Non-Hodgkin
47
Lymphoma, Mantle-Cell
45
Lymphoma, B-Cell, Marginal Zone
45
Leukemia, Lymphocytic, Chronic, B-Cell
40
Lymphoma, B-Cell
31
Recurrence
20
Burkitt Lymphoma
20
Waldenstrom Macroglobulinemia
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Neoplasms
16
Leukemia
11
Leukemia, Hairy Cell
7
Lymphoproliferative Disorders
5
Hodgkin Disease
5
Hematologic Neoplasms
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Hematologic Diseases
4
Dendritic Cell Sarcoma, Interdigitating
4
Neoplasm, Residual
3
Lymphoma, AIDS-Related
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Biphenotypic, Acute
3
Epstein-Barr Virus Infections
3
beta-Thalassemia
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Interventions
ruxolitinib
23
Cyclophosphamide
13
Whole-Body Irradiation
10
Tacrolimus
9
Mycophenolic Acid
9
fludarabine phosphate
8
fludarabine
8
Stem Cell Transplantation
8
Specimen Handling
7
Peripheral Blood Stem Cell Transplantation
7
Busulfan
5
Azacitidine
5
navitoclax
4
Sirolimus
4
Melphalan
4
Biopsy
4
luspatercept
3
fedratinib
3
Methotrexate
3
Cyclosporine
3
venetoclax
2
selinexor
2
parsaclisib
2
letermovir
2
itacitinib
2
bomedemstat
2
Injections
2
INCB057643
2
INCB039110
2
Hematopoietic Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
Rituximab
×
1 year
×
Clear all
No trials found.